{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:17:14Z","timestamp":1790691434610,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,6]],"date-time":"2022-11-06T00:00:00Z","timestamp":1667692800000},"content-version":"vor","delay-in-days":2927,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100018817","name":"LUPUS UK","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100018817","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000801","name":"Bayer Healthcare","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000801","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1111\/jth.12722","type":"journal-article","created":{"date-parts":[[2014,9,7]],"date-time":"2014-09-07T21:23:10Z","timestamp":1410124990000},"page":"1801-1809","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":85,"title":["Anti\u2010protein\u00a0C antibodies are associated with resistance to endogenous protein\u00a0C activation and a severe thrombotic phenotype in antiphospholipid syndrome"],"prefix":"10.1016","volume":"12","author":[{"given":"D.R.J.","family":"Arachchillage","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Efthymiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.J.","family":"Mackie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.S.","family":"Lawrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.J.","family":"Machin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 1","key":"10.1111\/jth.12722_bb0010","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/jth.12247","article-title":"Mechanisms of anticoagulant and cytoprotective actions of the protein\u00a0C pathway","volume":"11","author":"Bouwens","year":"2013","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12722_bb0015","doi-asserted-by":"crossref","first-page":"31869","DOI":"10.1016\/S0021-9258(18)31776-9","article-title":"The mechanism of inactivation of human factor\u00a0V and human factor\u00a0Va by activated protein\u00a0C","volume":"269","author":"Kalafatis","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1111\/jth.12722_bb0020","doi-asserted-by":"crossref","first-page":"21158","DOI":"10.1074\/jbc.270.36.21158","article-title":"Peptide bond cleavages and loss of functional activity during inactivation of factor\u00a0Va and factor\u00a0VaR506Q by activated protein\u00a0C","volume":"270","author":"Nicolaes","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1111\/jth.12722_bb0025","doi-asserted-by":"crossref","first-page":"643","DOI":"10.7326\/0003-4819-130-8-199904200-00004","article-title":"Activated protein\u00a0C resistance and factor\u00a0V Leiden mutation are independent risk factors for venous thromboembolism","volume":"130","author":"Rodeghiero","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1111\/jth.12722_bb0030","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1182\/blood.V97.4.844","article-title":"Acquired activated protein\u00a0C resistance is associated with lupus anticoagulants and thrombotic events in pediatric patients with systemic lupus erythematosus","volume":"97","author":"Male","year":"2001","journal-title":"Blood"},{"key":"10.1111\/jth.12722_bb0035","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1373\/clinchem.2004.043414","article-title":"Acquired activated protein\u00a0C resistance associated with IgG antibodies against beta2\u2010glycoprotein\u00a0I and prothrombin as a strong risk factor for venous thromboembolism","volume":"51","author":"Nojima","year":"2005","journal-title":"Clin Chem"},{"key":"10.1111\/jth.12722_bb0040","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1055\/s-0037-1613291","article-title":"Acquired activated protein\u00a0C resistance associated with anti\u2010protein\u00a0S antibody as a strong risk factor for DVT in non\u2010SLE patients","volume":"88","author":"Nojima","year":"2002","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.12722_bb0045","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1055\/s-0038-1650355","article-title":"Autoantibodies to phospholipid\u2010binding plasma proteins in patients with thrombosis and phospholipid\u2010reactive antibodies","volume":"75","author":"Pengo","year":"1996","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.12722_bb0050","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1365-2141.1990.tb07843.x","article-title":"Inhibition of activated protein\u00a0C and its cofactor protein\u00a0S by antiphospholipid antibodies","volume":"76","author":"Malia","year":"1990","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.12722_bb0055","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1136\/jcp.46.10.908","article-title":"Role of beta\u00a02\u2010glycoprotein\u00a0I and anti\u2010phospholipid antibodies in activation of protein\u00a0C in\u00a0vitro","volume":"46","author":"Keeling","year":"1993","journal-title":"J Clin Pathol"},{"key":"10.1111\/jth.12722_bb0060","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1055\/s-0038-1650220","article-title":"beta\u00a02\u2010Glycoprotein\u00a0I modulates the anticoagulant activity of activated protein\u00a0C on the phospholipid surface","volume":"75","author":"Mori","year":"1996","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.12722_bb0065","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1373\/clinchem.2008.112243","article-title":"Prediction of recurrent venous thromboembolism by endogenous thrombin potential and D\u2010dimer","volume":"54","author":"Eichinger","year":"2008","journal-title":"Clin Chem"},{"key":"10.1111\/jth.12722_bb0070","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1055\/s-0037-1614109","article-title":"Phenotyping the clotting system","volume":"84","author":"Hemker","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.12722_bb0075","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1159\/000073575","article-title":"The calibrated automated thrombogram (CAT): a universal routine test for hyper\u2010 and hypocoagulability","volume":"32","author":"Hemker","year":"2002","journal-title":"Pathophysiol Haemost Thromb"},{"key":"10.1111\/jth.12722_bb0080","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1160\/TH06-03-0179","article-title":"Use of calibrated automated thrombinography +\/\u2013 thrombomodulin to recognise the prothrombotic phenotype","volume":"96","author":"Dargaud","year":"2006","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.12722_bb0085","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1001\/jama.296.4.397","article-title":"Identification of patients at low risk for recurrent venous thromboembolism by measuring thrombin generation","volume":"296","author":"Hron","year":"2006","journal-title":"JAMA"},{"key":"10.1111\/jth.12722_bb0090","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1055\/s-0028-1104537","article-title":"The history of phenotypic testing in thrombosis and hemostasis","volume":"34","author":"Tripodi","year":"2008","journal-title":"Semin Thromb Hemost"},{"key":"10.1111\/jth.12722_bb0095","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1111\/j.1538-7836.2008.03117.x","article-title":"High rate of unprovoked recurrent venous thrombosis is associated with high thrombin\u2010generating potential in a prospective cohort study","volume":"6","author":"Besser","year":"2008","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12722_bb0100","first-page":"335","article-title":"Investigation of resistance to exogenous activated protein\u00a0C and activation of endogenous protein\u00a0C in thrombotic patients with or without antiphospholipid syndrome","volume":"11","author":"Arachchillage","year":"2013","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12722_bb0105","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.thromres.2004.06.017","article-title":"Phenotyping the haemostatic system by thrombography \u2013 potential for the estimation of thrombotic risk","volume":"114","author":"Regnault","year":"2004","journal-title":"Thromb Res"},{"key":"10.1111\/jth.12722_bb0110","first-page":"1639","article-title":"Thrombography allows reliable study of the protein\u00a0C system in APS and evidences a strong phenotypic heterogeneity","volume":"114","author":"Wahl","year":"2004","journal-title":"Thromb Res"},{"key":"10.1111\/jth.12722_bb0115","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1365-2141.2006.06385.x","article-title":"Decreased anticoagulant response to tissue factor pathway inhibitor type\u00a01 in plasmas from patients with lupus anticoagulants","volume":"136","author":"Liestol","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.12722_bb0120","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1159\/000071636","article-title":"Calibrated automated thrombin generation measurement in clotting plasma","volume":"33","author":"Hemker","year":"2003","journal-title":"Pathophysiol Haemost Thromb"},{"key":"10.1111\/jth.12722_bb0125","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1111\/j.1538-7836.2007.02734.x","article-title":"Activated protein\u00a0C resistance determined with a thrombin generation\u2010based test is associated with thrombotic events in patients with lupus anticoagulants","volume":"5","author":"Liestol","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12722_bb0130","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.thromres.2013.04.012","article-title":"Superficial vein thrombosis, thrombin generation and activated protein\u00a0C resistance as predictors of thromboembolic events in lupus and antiphospholipid patients. A prospective cohort study","volume":"132","author":"Zuily","year":"2013","journal-title":"Thromb Res"},{"key":"10.1111\/jth.12722_bb0135","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12722_bb0140","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1002\/art.23111","article-title":"Warfarin and the antiphospholipid syndrome: does one size fit all?","volume":"57","author":"Kasthuri","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1111\/jth.12722_bb0145","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1002\/art.23109","article-title":"A systematic review of secondary thromboprophylaxis in patients with antiphospholipid antibodies","volume":"57","author":"Ruiz\u2010Irastorza","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1111\/jth.12722_bb0150","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0049-3848(86)90145-3","article-title":"Fast functional protein\u00a0C assay using Protac, a novel protein\u00a0C activator","volume":"43","author":"Martinoli","year":"1986","journal-title":"Thromb Res"},{"key":"10.1111\/jth.12722_bb0155","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.thromres.2011.12.034","article-title":"Development and application of an automated chromogenic thrombin generation assay that is sensitive to defects in the protein\u00a0C pathway","volume":"130","author":"Green","year":"2012","journal-title":"Thromb Res"},{"key":"10.1111\/jth.12722_bb0160","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1111\/j.1538-7836.2010.03937.x","article-title":"Enhanced thrombin generation in patients with cirrhosis\u2010induced coagulopathy","volume":"8","author":"Gatt","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12722_bb0165","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1136\/ard.2003.017939","article-title":"High avidity anti\u2010beta\u00a02\u2010glycoprotein\u00a0I antibodies in patients with antiphospholipid syndrome","volume":"63","author":"Cucnik","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/jth.12722_bb0170","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1160\/TH08-06-0393","article-title":"Laboratory detection of the antiphospholipid syndrome via calibrated automated thrombography","volume":"101","author":"Devreese","year":"2009","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.12722_bb0175","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1055\/s-0038-1646483","article-title":"In\u00a0vitro studies of antiphospholipid antibodies and its cofactor, beta\u00a02\u2010glycoprotein\u00a0I, show negligible effects on endothelial cell mediated protein\u00a0C activation","volume":"66","author":"Oosting","year":"1991","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.12722_bb0180","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1055\/s-0038-1656363","article-title":"Immunoglobulin fractions isolated from patients with antiphospholipid antibodies prevent the inactivation of factor Va by activated protein C on human endothelial cells","volume":"68","author":"Borrell","year":"1992","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.12722_bb0185","doi-asserted-by":"crossref","first-page":"3512","DOI":"10.1002\/art.30525","article-title":"Interactions of human monoclonal and polyclonal antiphospholipid antibodies with serine proteases involved in hemostasis","volume":"63","author":"Lambrianides","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1111\/jth.12722_bb0190","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1160\/TH03-03-0151","article-title":"Antibodies directed to protein\u00a0S in patients with systemic lupus erythematosus: prevalence and clinical significance","volume":"90","author":"Bertolaccini","year":"2003","journal-title":"Thromb Haemost"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjth.12722","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjth.12722","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622041010?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622041010?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/jth.12722\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:09:06Z","timestamp":1761534546000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622041010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":37,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S1538783622041010"],"URL":"https:\/\/doi.org\/10.1111\/jth.12722","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti\u2010protein\u00a0C antibodies are associated with resistance to endogenous protein\u00a0C activation and a severe thrombotic phenotype in antiphospholipid syndrome","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/jth.12722","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}